Press release
The first patient clinical study for a Therapeutic vaccine against chronic hepatitis B has begun
Therapeutic vaccine
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72635
Market Overview
The global therapeutic vaccines market was valued at USD 3.9 billion in 2024 and is projected to reach USD 14.8 billion by 2034, growing at a CAGR of 14.2%.
Key Highlights:
• Market Size 2024: USD 3.9 billion
• Forecast 2034: USD 14.8 billion
• CAGR (2024-2034): 14.2%
• Primary Drivers: Rising cancer burden, advancements in immunotherapy, and supportive regulatory frameworks for innovative biologics.
• Challenges: High R&D costs, long clinical timelines, and regulatory complexity.
• Leading Players: Dendreon Pharmaceuticals, Gilead Sciences, Bristol-Myers Squibb, GlaxoSmithKline (GSK), Roche, CureVac, Moderna, and Merck & Co.
This market represents a next-generation pillar of immunotherapy, with cancer therapeutic vaccines leading the clinical pipeline.
Segmentation Analysis
By Type:
• Cancer vaccines
• Infectious disease vaccines
• Autoimmune disease vaccines
• Neurological disorder vaccines
• Others (allergy vaccines, rare diseases)
By Technology:
• DNA & RNA-based vaccines
• Recombinant protein vaccines
• Dendritic cell vaccines
• Peptide-based vaccines
• Viral vector-based vaccines
• Others (heat shock protein vaccines, tumor cell vaccines)
By Application:
• Oncology (prostate, lung, breast, melanoma, colorectal)
• HIV/AIDS
• Hepatitis B & C
• Alzheimer's disease
• Multiple sclerosis
• Others (allergies, emerging viral infections)
By End-User:
• Hospitals & clinics
• Specialty cancer centers
• Research institutes
• Pharmaceutical & biotechnology companies
Summary:
Oncology is the dominant application area, driven by the success of therapeutic cancer vaccines in late-stage clinical trials. Infectious disease vaccines, particularly for HIV and hepatitis, are expected to see steady adoption. DNA and RNA-based vaccines are gaining strong traction post-COVID-19, reshaping the therapeutic vaccine landscape.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72635/therapeutic-vaccines-market
Regional Analysis
North America
• Largest market due to robust biotech ecosystem, FDA approvals, and high investment in cancer immunotherapy.
• The U.S. leads in clinical trials for oncology vaccines and partnerships between biotech firms and universities.
Europe
• Strong presence in Germany, UK, and France, supported by EU's Horizon Europe research funding.
• Favorable regulatory environment for rare and orphan disease vaccines.
Asia-Pacific
• Fastest-growing region, led by China, Japan, South Korea, and India.
• Rapid adoption of immunotherapies, government healthcare reforms, and strong vaccine manufacturing capacity.
Middle East & Africa
• Early adoption stage, with GCC nations investing in advanced healthcare technologies.
• Increasing research collaborations and clinical trial participation.
Latin America
• Brazil and Mexico emerging as important vaccine R&D and clinical testing hubs.
• Growing interest in therapeutic vaccines for infectious diseases and oncology.
Summary:
While North America dominates, Asia-Pacific is forecast to post the fastest CAGR (15%+) through 2034, becoming a global hub for vaccine innovation and clinical development.
Market Dynamics
Key Growth Drivers:
• Rising cancer incidence and unmet medical needs.
• Advances in genomics, proteomics, and antigen identification.
• Expanding pipeline of therapeutic vaccines in oncology and infectious diseases.
• Government incentives for orphan and rare disease drug development.
Key Challenges:
• High cost of R&D and manufacturing.
• Long timelines for clinical development and approval.
• Limited patient awareness and reimbursement hurdles in some regions.
Latest Trends:
• Growth of mRNA-based therapeutic vaccines beyond COVID-19.
• Increasing focus on personalized cancer vaccines tailored to tumor profiles.
• Integration of AI and computational biology in vaccine design.
• Strategic partnerships between big pharma and biotech startups to accelerate pipelines.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72635
Competitor Analysis
Major Players in the Therapeutic Vaccines Market:
• Dendreon Pharmaceuticals - Known for Provenge, the first FDA-approved cancer vaccine.
• Gilead Sciences - Active in HIV therapeutic vaccine development.
• Bristol-Myers Squibb - Expanding immunotherapy portfolio with cancer vaccine research.
• GlaxoSmithKline (GSK) - Developing vaccines for infectious and autoimmune diseases.
• Roche - Advancing oncology vaccine programs in combination therapies.
• CureVac - Innovator in RNA-based therapeutic vaccines.
• Moderna - Leveraging mRNA platform for cancer and rare disease vaccines.
• Merck & Co. - Leader in immuno-oncology with ongoing vaccine trials.
Competitive Summary:
Competition is centered on innovation and clinical trial success. Startups specializing in mRNA and dendritic cell vaccines are gaining momentum, while established pharma companies dominate late-stage development. Mergers, acquisitions, and partnerships are common strategies to diversify pipelines.
Conclusion
The Therapeutic Vaccines Market is expected to expand rapidly, reaching USD 14.8 billion by 2034. With cancer vaccines at the forefront, followed by HIV and autoimmune applications, this market is shaping the future of personalized immunotherapy.
Key Takeaways:
• Market to grow at 14.2% CAGR (2024-2034).
• Oncology dominates applications, with mRNA and dendritic cell vaccines driving innovation.
• North America leads in adoption, while Asia-Pacific will be the fastest-growing region.
• Market competition is driven by clinical trial progress, partnerships, and technology innovation.
• Future opportunities lie in personalized vaccines, AI-driven design, and emerging infectious disease applications.
As therapeutic vaccines progress from research to mainstream medicine, they hold the promise of transforming patient outcomes, particularly in oncology and chronic infectious diseases, heralding a new era of immune-powered therapeutics.
This report is also available in the following languages : Japanese (治療用ワクチン市場), Korean (치료용 백신 시장), Chinese (治疗性疫苗市场), French (Marché des vaccins thérapeutiques), German (Markt für therapeutische Impfstoffe), and Italian (Mercato dei vaccini terapeutici), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72635/therapeutic-vaccines-market#request-a-sample
Our More Reports:
Wireless Healthcare Market
https://exactitudeconsultancy.com/reports/73677/wireless-healthcare-market
Healthcare Technology Management Market
https://exactitudeconsultancy.com/reports/73678/healthcare-technology-management-market
AI in Mental Health Market
https://exactitudeconsultancy.com/reports/73679/ai-in-mental-health-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The first patient clinical study for a Therapeutic vaccine against chronic hepatitis B has begun here
News-ID: 4202018 • Views: …
More Releases from Exactitude Consultancy
A Novel Approach to Molecular Cancer Imaging Technologies: Aptamers
The global Aptamers Market is gaining strong momentum as biotechnology and pharmaceutical companies increasingly leverage aptamers for drug discovery, diagnostics, targeted therapeutics, and biomarker research. Aptamers are short, single-stranded DNA, RNA, or peptide molecules that bind with high specificity and affinity to a wide range of targets, from proteins to small molecules and even entire cells. Often compared to antibodies, aptamers offer several advantages-chemical stability, lower production cost, ease of…
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased …
Introduction
Flow cytometry has become a cornerstone technology in modern biomedical research and clinical diagnostics. By enabling rapid, quantitative, and multiparametric analysis of single cells in suspension, flow cytometry has transformed fields such as immunology, oncology, stem cell biology, and infectious disease research. The technique supports critical applications like immunophenotyping, cell sorting, biomarker detection, and drug discovery.
As the demand for high-throughput cell-based analysis grows, flow cytometry services are increasingly sought by…
BlackRock removes plant-based meat from its nutrition fund
The global Plant-Based Meats Market is undergoing a transformative phase, driven by shifting consumer preferences, environmental concerns, and advancements in food technology. Plant-based meats are designed to mimic the taste, texture, and nutritional profile of traditional animal meat while offering sustainable and ethical benefits. With climate change, rising demand for protein, and health-conscious lifestyles shaping food choices, plant-based meats are gaining rapid traction across supermarkets, restaurants, and online platforms.
Download Full…
Elegen and Integrated DNA Technologies collaborate to transform the market for l …
The global DNA Synthesis Market is rapidly becoming the backbone of modern biotechnology, genomics, and personalized medicine. DNA synthesis-the artificial creation of DNA sequences-has evolved from basic laboratory applications into a transformative technology powering synthetic biology, precision medicine, vaccine development, agricultural biotech, and drug discovery. Demand is surging as research institutions, pharmaceutical companies, and biotech firms increasingly require custom DNA fragments, oligonucleotides, and gene libraries to accelerate innovation. With automation,…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
